Bacteriological profile and antimicrobial resistance patterns of bloodstream infections in a tertiary care hospital, Eastern India

2016 ◽  
Vol 5 (4) ◽  
pp. 210 ◽  
Author(s):  
Muktikesh Dash ◽  
RakeshKumar Panda ◽  
Dharitri Mohapatra ◽  
BimochProjna Paty ◽  
Gitanjali Sarangi ◽  
...  
2014 ◽  
Vol 9 (1) ◽  
pp. 24039 ◽  
Author(s):  
Krishnappa Lakshmana Gowda ◽  
Mohammed A. M. Marie ◽  
Yazeed A Al-Sheikh ◽  
James John ◽  
Sangeetha Gopalkrishnan ◽  
...  

2020 ◽  
Author(s):  
Vijayalaxmi V Mogasale ◽  
Prakash Saldanha ◽  
Vidya Pai ◽  
Rekha PD ◽  
Vittal Mogasale

Abstract Background There is global consensus that Antimicrobial Resistance (AMR) poses an unprecedented challenge to modern medicine as we know it today; and the lack of new antibiotics in the pipeline is compounding the threat to contain emerging drug-resistant infections. In 2017, the World Health Organization (WHO) has articulated a priority pathogens list (PPL) to provide strategic direction to research and development of new anti-microbials. Anti-microbial resistance patterns of selected ‘drug-bug’ combinations based on the WHO-PPL in one tertiary health care facility in India are explored in this paper. Methods Culture reports of laboratory specimens, collected between 1st January 2014 and 31st October 2019 from paediatric patients in a tertiary care hospital in India, were retrospectively extracted. The antimicrobial susceptibility patterns for selected antimicrobials based on the WHO-PPL are analysed and reported. Results Of 12,256 culture specimens screened, 2,335 (19%) showed culture positivity; of which 1,556 were organisms from the WHO-PPL. E. coli was the most common organism isolated (37%) followed by Staphylococcus aureus (16%). Total 72% of E. coli were extended-spectrum beta-lactamases producers, 55% of Enterobacteriaceae were resistant to 3rd generation cephalosporins, and 53% of Staphylococcus aureus were Methicillin resistant. Time-trend analysis of the data showed continued high resistance to carbapenem in E coli, Klebsiella pneumoniae and Enterobacter cloacae. Conclusions The AMR trends and prevalence patterns are likely to be different, across various local settings, than as defined at the national level or the WHO-PPL. This difference needs to be recognised in decision and policy making. It is critical, that the evidence used at national and global levels, have reasonable geographical and population representation through standardised and more granular AMR surveillance, in order to improve the effectiveness of the overall national AMR response.


Sign in / Sign up

Export Citation Format

Share Document